Business Information
The group’s principal activities include discovering, developing and commercializing therapeutic products. The products of the group include Sulfonylureas, Meglitinides, Biguanides and Incretin mimetics. The group products sold under the trade names Humalog(R) Prandin(R) and Starlix(R) Glucotrol(R), Diabeta(R), Glynase(R), Micronase(R) and Amaryl(R). The group operates from the United States. The revenue of the group for the year 2006 was $100 (thousands).
|
|
Name |
Title
|
Email
|
| Alfred Mann | Chmn., CEO | N/A | | Hakan Edstrom | Dir., COO, Pres. | N/A | | Juergen Martens | Corporate VP - Technical Operations, CTO | N/A | | Peter Richardson | Corporate VP, Chief Scientific Officer | N/A | | Richard Anderson | CFO, Corporate VP | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 100 | (230,548) | | 2005 | N/A | (114,338) | | 2004 | N/A | (75,992)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
